SUBSCRIBE

Breaking News on Contract Research, Manufacturing & Clinical Trials

Drug delivery, formulation

Products

Watch now!On-Demand Supplier Webinar

Bioavailability market dynamics - William Reed Business Media

30-Sep-2014 - How healthy is demand for bioavailability enhancement services? Is the growth of the generics sector driving the market or do innovative pharma firms determine the type of solubility solutions that are available.When biopharmaceutical are injected they are 100% bioavailable, but...
Watch now!On-Demand Supplier Webinar

A brief history of bioavailability - William Reed Business Media

30-Sep-2014 - Tablets have been around for almost 200 years. In this presentation we trace the history of their development, from the accidental invention of the sustained release pill through to the latest breakthroughs in bioavailability enhancement, this talk will take us...
Download now!Case study

MARKEN DELIVERS MEDICINE TO HELP SAVE A CHILD’S LIFE - Marken

26-Sep-2014 - A child in Australia is critically ill and in immediate need of a drug available only in the United Kingdom. Marken’s team of experts uses its immediate access to validated packaging and airline contacts to secure a direct flight. Through...
Download now!Technical / white paper

Viral-Challenge Studies: Regulatory Requirements - SGS

15-Sep-2014 - The use of viral-challenge studies as POC studies is gaining wider acceptance. This approach accelerates the selection of a safe and effective dose and dosing regimen for a new antiviral drug/ vaccine as it allows for early detec­tion of efficacy...
Download now!Technical / white paper

7 Common Myths about QP Training Debunked : A Guide for Senior Managers - Reading Scientific Services Limited

11-Sep-2014 - The role of the Qualified Person (QP) in the pharmaceutical industry is mandated by law (Directive 2001/83/EC, Directive 2001/20/EC, UK SI 2012/1916, UK SI 2004/103). Every holder of a relevant Manufacturers Authorisation (human and veterinary) must have at least one...
Download now!Clinical study

Learn the risk factors of metabolic syndrome and the role central labs play in aiding its detection - ACM Global Central Laboratory

17-Jun-2014 - Metabolic syndrome, a serious condition impacting adults and children in all genders, races and ethnicities, can lead to fatal outcomes if not detected and treated. The key risk factors of metabolic syndrome were identified approximately 250 years ago. However, there...
Download now!Technical / white paper

Are there Any Markets left to Emerge? - World Courier

02-Jun-2014 - North America, Western Europe and—to a lesser extent—Australasia once served as prime locations for the majority of research. But these Western markets are approaching saturation, which has led to a lack of naive patients who are available and willing to...
Download now!Technical / white paper

Excipients for Multilayer Tablets - JRS PHARMA LP

07-May-2014 - Multi-layered tablets bring together differently formulated powder mixtures, which typically contain different APIs, into a single tablet with two or more layers. They offer benefits for overcoming API-API interactions and stability issues, tailoring dissolution profiles, and bringing brand recognition to...
Download now!Case study

Fast and Flexible – Early Phase Manufacturing - Patheon Inc

05-May-2014 - Early-stage manufacturers of oral solid dosage forms need to be fast and flexible to generate development pathways that can cope with variable API characteristics as well as highly potent molecules. Technology, risk assessment, Quality by Design and scale up are...
Download now!Technical / white paper

Meeting the challenges of complex drug substances - Vetter Pharma International GmbH

15-Apr-2014 - Realizing the full potential of an injectable drug compound is no small task. In the months and years that lead from the discovery phase to the rigorous demands of a commercial launch, unexpected scientific and technical challenges can slow development...
Download now!Technical / white paper

White Paper: Model-Based Drug Development - SGS Life Science Services

14-Apr-2014 - In this white paper learn how MBDD can help you make better drug development decisions through the use of mathematical models. Read how such models can be applied to population pharmacokinetics, dose-response characterization, and pediatrics. 
Watch now!On-Demand Supplier Webinar

Dow AFFINISOL™ polymers for Solubility Enhancement - Dow Pharma & Food Solutions

12-Mar-2014 - Dow’s AFFINISOL™ line of excipients include AFFINISOL™ HMPCAS for spray drying applications and AFFINISOL™ HPMC for hot melt extrusion (HME) applications. Hypromellose acetate succinate (HPMCAS) has proven effective at producing stable amorphous solid dispersions for poorly soluble APIs. We will highlight: •...
Watch now!On-Demand Supplier Webinar

How glass-forming polymers improve bioavailability / Enhanced oral bioavailability with Soluplus® – case study - BASF SE

12-Mar-2014 - How glass-forming polymers improve bioavailabilityPolymers are essential components of oral solid dosage forms and used as binders, disintegrants or coatings. Given the increase in poorly water-soluble drugs, not only well-known but also specifically designed polymers (e.g. Soluplus®) can be used...
Watch now!On-Demand Supplier Webinar

Role of excipients in design of solid amorphous drug dispersions for delivery of poorly water-soluble drugs - Ashland

10-Mar-2014 - Most new drug candidates suffer from poor water- solubility leading to rate limiting dissolution, slow absorption and limited bioavailability. Solid amorphous drug dispersions are most commonly used improve bioavailability by enhancing drug solubility. The selection of the right solid dispersion...
Download now!Case study

Controlled Release and Bioavailability Enhancement -

28-Oct-2013 - Metrics provides product development that leverages proprietary pharmaceutical technologies in the areas of: •    Customized Controlled Release Drug Delivery •    Bioavailability Enhancement •    Taste Masking (liquid and solid presentations)When applied appropriately, these technologies can deliver therapeutic and convenience benefits to...
Download now!Data sheet

505(b)(2): 10 Years and Running with 300+ Approvals - Camargo

21-Oct-2013 - In 2003, the FDA unleashed the 505(b)(2) pathway. With a record 47 approvals in 2012, the pathway is helping product developers secure up to 7 years of market exclusivity.Visit us at AAPS booth 4304 and read our white paper to learn more.
Watch now!On-Demand Supplier Webinar

New Guidelines for Stabilization of Proteins by Freeze Drying: Formulation and Process Heresy - Baxter

17-Oct-2013 - Over the years a number of informal guidelines or “rules” for the formulation and processing of proteins for freeze-drying have been developed. However, in recent years it has become obvious that some of these rules need modification. In this presentation,...
Download now!Technical / white paper

(b)(2) or not (b)(2)? That is the question. - Camargo

19-Aug-2013 - 505(b)(2) is more than a regulatory pathway - for many, it’s a unique strategy that can often result in product approval with lower risk, reduced development cost and faster speed to market. So, is (b)(2) for you? To find out...
Watch now!On-Demand Supplier Webinar

Exploring New Frontiers in Direct to Patient Home Delivery Services for Clinical Trials Materials - Marken

07-Aug-2013 - Exploring New Frontiers in Direct to Patient (DTP) Home Delivery Services for Clinical Trial Materials provides an in-depth look at reasons to consider a DTP solution. Included in the discussion are concerns with the traditional distribution channels, advantages and challenges...
Download now!Case study

Pharmaceutical Development for ADCs - Baxter

05-Aug-2013 - Formulation, process, and analytical development for ADCs is complex. While an aqueous solution formulation may be preferred over a lyophilized product, it is useful to initially pursue a dual path and develop drug product formulations for both a sterile solution...

Key Industry Events

 

Access all events listing

Our events, Events from partners...

Product Innovation